Mineralys Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know

Mineralys Therapeutics, Inc MLYS IPO will take place February, 10 on the NASDAQ exchange under the ticker MLYS.

The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on August 09, 2023.

See also: Benzinga IPO Calendar

About Mineralys Therapeutics, Inc

Mineralys Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.